C6 technology lets you monitor response to treatment
A unique property of the C6 antibody is that levels decline sharply after treatment, before the body can produce memory (B) cells. The lack of memory (B) cells means the body does not maintain a titer after the spirochetes are killed.
Other tests, such as the Lyme titer (IFA) and Western blot tests, measure antibodies that can persist at high levels long after treatment, making it difficult to determine whether the spirochetes are still present, even after treatment.
Case Study
 |